Correction: Induced pluripotent stem cell-derived monocytic cell lines from a NOMID patient serve as a screening platform for modulating NLRP3 inflammasome activity.

Correction: Induced pluripotent stem cell-derived monocytic cell lines from a NOMID patient serve as a screening platform for modulating NLRP3 inflammasome activity.

[This corrects the article DOI: 10.1371/journal.pone.0237030.].

Bibliographic Details
Main Authors:	Ryosuke Seki, Akira Ohta, Akira Niwa, Yoshinori Sugimine, Haruna Naito, Tatsutoshi Nakahata, Megumu K Saito
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2021-01-01
Series:	PLoS ONE
Online Access:	https://doi.org/10.1371/journal.pone.0249807

Similar Items

Induced pluripotent stem cell-derived monocytic cell lines from a NOMID patient serve as a screening platform for modulating NLRP3 inflammasome activity.
by: Ryosuke Seki, et al.
Published: (2020-01-01)

Pluripotent stem cell‐based screening identifies CUDC‐907 as an effective compound for restoring the in vitro phenotype of Nakajo‐Nishimura syndrome
by: Naoya Kase, et al.
Published: (2021-03-01)

Pluripotent stem cell model of early hematopoiesis in Down syndrome reveals quantitative effects of short-form GATA1 protein on lineage specification.
by: Shiori Matsuo, et al.
Published: (2021-01-01)

Robust and highly-efficient differentiation of functional monocytic cells from human pluripotent stem cells under serum- and feeder cell-free conditions.
by: Masakatsu D Yanagimachi, et al.
Published: (2013-01-01)

A novel serum-free monolayer culture for orderly hematopoietic differentiation of human pluripotent cells via mesodermal progenitors.
by: Akira Niwa, et al.
Published: (2011-01-01)

Selective development of myogenic mesenchymal cells from human embryonic and induced pluripotent stem cells.
by: Tomonari Awaya, et al.
Published: (2012-01-01)

N-Acetylcysteine prevents amyloid-β secretion in neurons derived from human pluripotent stem cells with trisomy 21
by: Hiromitsu Toshikawa, et al.
Published: (2021-08-01)

Staphylococcus aureus alpha-hemolysin activates the NLRP3-inflammasome in human and mouse monocytic cells.
by: Robin R Craven, et al.
Published: (2009-10-01)

Lysophosphatidylcholine Induces NLRP3 Inflammasome-Mediated Foam Cell Formation and Pyroptosis in Human Monocytes and Endothelial Cells
by: Rafael Corrêa, et al.
Published: (2020-01-01)

Priming Is Dispensable for NLRP3 Inflammasome Activation in Human Monocytes In Vitro
by: Anna Gritsenko, et al.
Published: (2020-09-01)

Corrigendum: Priming Is Dispensable for NLRP3 Inflammasome Activation in Human Monocytes In Vitro
by: Anna Gritsenko, et al.
Published: (2021-09-01)

EXPERIENCE IN APPLICATION OF CANAKINUMAB IN PATIENTS WITH CRYOPYRIN-ASSOCIATED SYNDROME (SYNDROME CINCA/NOMID)
by: T. V. Sleptsova, et al.
Published: (2014-05-01)

Impact of human monocyte and macrophage polarization on NLR expression and NLRP3 inflammasome activation.
by: Fawaz Awad, et al.
Published: (2017-01-01)

Mitochondria Fusion upon SERCA Inhibition Prevents Activation of the NLRP3 Inflammasome in Human Monocytes
by: Ana Catarina Pereira, et al.
Published: (2022-01-01)

NLRP3 inflammasome in peripheral blood monocytes as a risk factor for early -onset preeclampsia
by: Hong Yang, et al.
Published: (2023-05-01)

Experience with an IL-1ß inhibitor (anakinra) in a patient with CINCA/NOMID syndrome
by: S O Salugina, et al.
Published: (2012-09-01)

Identification of hepatic niche harboring human acute lymphoblastic leukemic cells via the SDF-1/CXCR4 axis.
by: Itaru Kato, et al.
Published: (2011-01-01)

Role of NLRP3 inflammasome activation in HCC cell progression
by: Bingling Dai, et al.
Published: (2023-09-01)

The NLRP3 inflammasome in macrophages is stimulated by cell‐free hemoglobin
by: Ciara M. Shaver, et al.
Published: (2020-11-01)

Inhibiting the NLRP3 Inflammasome
by: Lina Y. El-Sharkawy, et al.
Published: (2020-11-01)

Gubentongluo decoction alleviates NLRP3 inflammasome in IgAN cell model
by: Wei Meng, et al.
Published: (2023-12-01)

Inhibition of NLRP3 inflammasome activation by cell-permeable stapled peptides
by: Verma, Chandra Shekhar, et al.
Published: (2019)

Research Progress of Mitochondrial Mechanism in NLRP3 Inflammasome Activation and Exercise Regulation of NLRP3 Inflammasome
by: Tan Zhang, et al.
Published: (2021-10-01)

The Role of Inflammasome-Dependent and Inflammasome-Independent NLRP3 in the Kidney
by: Yang Gyun Kim, et al.
Published: (2019-11-01)

Homeostatic tissue responses in skin biopsies from NOMID patients with constitutive overproduction of IL-1β.
by: Pamela Aubert, et al.
Published: (2012-01-01)

Induced Pluripotent Stem Cell-Derived Monocytes/Macrophages in Autoinflammatory Diseases
by: Takayuki Tanaka, et al.
Published: (2022-05-01)

The Significance of NLRP Inflammasome in Neuropsychiatric Disorders
by: Yao Shen, et al.
Published: (2022-08-01)

Vitamin D and the NLRP3 Inflammasome
by: Matthew Tunbridge, et al.
Published: (2020-11-01)

The NLRP3-Inflammasome in Health and Disease
by: Anna Perri
Published: (2022-10-01)

Targeting the NLRP3 Inflammasome in Glaucoma
by: Sophie Coyle, et al.
Published: (2021-08-01)

The NLRP1 inflammasome in skin diseases
by: Marc Burian, et al.
Published: (2023-02-01)

Role of the NLRP3 Inflammasome in Preeclampsia
by: Koumei Shirasuna, et al.
Published: (2020-02-01)

Spotlight on the NLRP3 inflammasome pathway
by: Groslambert M, et al.
Published: (2018-09-01)

Pharmacological Inhibitors of the NLRP3 Inflammasome
by: Ayesha Zahid, et al.
Published: (2019-10-01)

NLRP3 inflammasome in metabolic syndrome
by: Fang Wang, et al.
Published: (2021-04-01)

Regulation of NLRP3 Inflammasome by Phosphorylation
by: Nan Song, et al.
Published: (2018-10-01)

Role of NLRP3 inflammasome in diabetes and COVID-19 role of NLRP3 inflammasome in the pathogenesis and treatment of COVID-19 and diabetes NLRP3 inflammasome in diabetes and COVID-19 intervention
by: Jiayu Zhang, et al.
Published: (2023-10-01)

High-Yield Human Induced Pluripotent Stem Cell-Derived Monocytes and Macrophages Are Functionally Comparable With Primary Cells
by: Di Cui, et al.
Published: (2021-04-01)

Mitochondrial redox modulation of NLRP3 inflammasome in differentiated THP-1 cells
by: Abas, Razif, et al.
Published: (2019)

Autophagy in Atherosclerotic Plaque Cells: Targeting NLRP3 Inflammasome for Self-Rescue
by: Xuelian Li, et al.
Published: (2022-12-01)